Table 2. Correlation of ESCC Clinicopathological Features with Maspin Expression and Subcellular Localization.

Variable	Cases (n = 84)	Maspin Expression		P Value	Nuclear Maspin		P Value	Cytoplasmic Maspin		P Value
		Weak	Strong		Weak	Strong		Weak	Strong
Sex
Male	64	26 (40%)	38 (60%)	0.653	28 (43%)	36 (57%)	0.767	36(57%)	28 (43)	0.922
Female	20	7 (35%)	13 (65%)		8 (40%)	12 (60%)		11 (55%)	9 (45%)
Age
<60	42	16 (37%)	26 (63%)	0.823	17 (40%)	25 (60%)	0.659	25 (60%)	17 (40%)	0.510
≥60	42	17 (40%)	25 (60%)		19 (45%)	23 (55%)		22 (52%)	20 (48%)
Differentiation
Well	19	8 (43%)	11 (57%)	0.706	9 (47%)	10 (53%)	0.475	8 (41%)	11 (69%)	0.383
Moderate	43	18 (42%)	25 (58%)		20 (46%)	23 (54%)		26 (60%)	17 (40%)
Poor	22	7 (32%)	15 (68%)		7 (31%)	15 (69%)		13 (61%)	9 (39%)
Lymph node metastasis
Negative	33	11 (33%)	22 (67%)	0.369	14 (43%)	19 (57%)	0.949	18 (58%)	15 (42%)	0.834
Positive	51	22 (43%)	29 (56%)		22 (40%)	29 (60%)		29 (60%)	22 (40%)
Pathologic stage
I+II	40	13 (32%)	27 (65%)	0.225	16 (40%)	24 (60%)	0.614	19 (48%)	21 (52%)	0.137
III	44	20 (45%)	24 (54%)		20 (45%)	24 (55%)		28 (63%)	16 (37%)